MX2024010123A - Capsula de gel blando de acido valproico de liberacion modificada. - Google Patents

Capsula de gel blando de acido valproico de liberacion modificada.

Info

Publication number
MX2024010123A
MX2024010123A MX2024010123A MX2024010123A MX2024010123A MX 2024010123 A MX2024010123 A MX 2024010123A MX 2024010123 A MX2024010123 A MX 2024010123A MX 2024010123 A MX2024010123 A MX 2024010123A MX 2024010123 A MX2024010123 A MX 2024010123A
Authority
MX
Mexico
Prior art keywords
valproic acid
modified release
softgel capsule
softgel
capsule
Prior art date
Application number
MX2024010123A
Other languages
English (en)
Spanish (es)
Inventor
Karunakar Sukuru
Qi Fang
Original Assignee
Scherer Technologies Llc R P
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Scherer Technologies Llc R P filed Critical Scherer Technologies Llc R P
Publication of MX2024010123A publication Critical patent/MX2024010123A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5052—Proteins, e.g. albumin
    • A61K9/5057—Gelatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4816—Wall or shell material
    • A61K9/4825—Proteins, e.g. gelatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4833—Encapsulating processes; Filling of capsules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
MX2024010123A 2022-02-18 2023-02-17 Capsula de gel blando de acido valproico de liberacion modificada. MX2024010123A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US202263311559P 2022-02-18 2022-02-18
PCT/US2023/013277 WO2023158777A1 (en) 2022-02-18 2023-02-17 Modified release valproic acid softgel capsule

Publications (1)

Publication Number Publication Date
MX2024010123A true MX2024010123A (es) 2024-08-27

Family

ID=87579078

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2024010123A MX2024010123A (es) 2022-02-18 2023-02-17 Capsula de gel blando de acido valproico de liberacion modificada.

Country Status (12)

Country Link
US (1) US20250177312A1 (cg-RX-API-DMAC10.html)
EP (1) EP4479033A4 (cg-RX-API-DMAC10.html)
JP (1) JP2025506678A (cg-RX-API-DMAC10.html)
KR (1) KR20240145031A (cg-RX-API-DMAC10.html)
CN (1) CN118647373A (cg-RX-API-DMAC10.html)
AR (1) AR128560A1 (cg-RX-API-DMAC10.html)
AU (1) AU2023221972A1 (cg-RX-API-DMAC10.html)
CA (1) CA3244352A1 (cg-RX-API-DMAC10.html)
CO (1) CO2024012216A2 (cg-RX-API-DMAC10.html)
IL (1) IL314788A (cg-RX-API-DMAC10.html)
MX (1) MX2024010123A (cg-RX-API-DMAC10.html)
WO (1) WO2023158777A1 (cg-RX-API-DMAC10.html)

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6437006B1 (en) * 1999-09-27 2002-08-20 American Cyanamid Company Pharmaceutical carrier formulation
US20070082046A1 (en) * 2005-10-11 2007-04-12 Banner Pharmacaps, Inc. Enteric valproic acid
CA2853965A1 (en) * 2011-11-03 2013-05-10 Gtx, Inc. Pharmaceutical compositions of selective androgen receptor modulators and methods of use thereof
WO2015195989A1 (en) * 2014-06-20 2015-12-23 Banner Life Sciences Llc Enteric soft capsule compositions
US20170312226A1 (en) * 2016-04-28 2017-11-02 Ascent Pharmaceuticals, Inc. Pharmaceutical dosage forms
CN114072138A (zh) * 2019-06-03 2022-02-18 R.P.谢勒技术有限公司 延迟释放软凝胶胶囊
EP4674410A3 (en) * 2019-10-28 2026-03-18 R.P. Scherer Technologies, LLC Delayed release softgel capsules in higher ph environment
CA3185807A1 (en) * 2020-06-02 2021-12-02 R.P. Scherer Technologies, Llc Delayed release softgel capsules

Also Published As

Publication number Publication date
AR128560A1 (es) 2024-05-22
IL314788A (en) 2024-10-01
CA3244352A1 (en) 2023-08-24
KR20240145031A (ko) 2024-10-04
WO2023158777A1 (en) 2023-08-24
CO2024012216A2 (es) 2024-09-30
US20250177312A1 (en) 2025-06-05
CN118647373A (zh) 2024-09-13
EP4479033A1 (en) 2024-12-25
AU2023221972A1 (en) 2024-09-19
EP4479033A4 (en) 2026-03-04
JP2025506678A (ja) 2025-03-13

Similar Documents

Publication Publication Date Title
US7770361B2 (en) Powder compaction and enrobing
TWI257871B (en) Pharmaceutical formulation
JP5192816B2 (ja) 非ゼラチン軟質カプセルシステム
CA2341024A1 (en) Non-gelatin substitutes for oral delivery capsules, their composition and process of manufacture
US20150004226A1 (en) Gelatin/alginate delayed release capsules comprising omega-3 fatty acids, and methods and uses thereof
JPS6322032A (ja) ゼラチン封入徐放性組成物及びその製造方法
FR3089418B1 (fr) Capsules à base d’amidon riche en amylose et leur procédé de fabrication
ES2042731T3 (es) Comprimidos de forma oblonga ("caplets") no encapsulados que estan provistos de un revestimiento de gelatina y procedimiento para fabricarlos.
IL276943B1 (en) Enteric softgel capsules
CA2633924A1 (en) Gastric reflux resistant dosage forms
CA2392545A1 (en) Pharmaceutical formulations for thyroid hormones
JP2005539019A (ja) 錠剤及びカプレットのためのフィルムコーティング
GB1455884A (en) Production of capsules
MY142365A (en) Non-gelatin based capsules
CN110721172A (zh) 一种艾司奥美拉唑镁肠溶微片及其制备方法
CO2024012216A2 (es) Cápsula blanda de ácido valproico de liberación modificada
ES434971A1 (es) Metodo para producir un preparado farmaceutico que comprendeuna solucin de digoxina en una envolvente de capsula solu- ble.
MX2024015306A (es) Capsula de gelatina blanda de bisacodilo enterico
MX2023004441A (es) Composiciones de relleno de liberacion controlada y capsulas que las contienen.
CN101209247B (zh) 一种结肠靶向制剂的制备方法
MX2022011549A (es) Capsulas de gel blando.
GB1147245A (en) Method for the production of slow release pharmaceutical compositions
JP2020055766A5 (cg-RX-API-DMAC10.html)
MX2025001800A (es) Capsulas de gel blando entericas recubiertas
JPS6330891B2 (cg-RX-API-DMAC10.html)